Literature DB >> 25512092

Liver cancer in Malaysia: epidemiology and clinical presentation in a multiracial Asian population.

Khean-Lee Goh1, Hamizah Razlan, Juanda Leo Hartono, Choon-Seng Qua, Boon-Koon Yoong, Peng-Soon Koh, Basri Johan Jeet Abdullah.   

Abstract

OBJECTIVE: Hepatocellular carcinoma (HCC) is an important cancer in Malaysia. This study aimed to determine the epidemiological characteristics and clinical presentations of patients in a multiracial population consisting of three major Asian races: Malays, Chinese and Indians.
METHODS: Consecutive patients with HCC were prospectively studied from 2006 to 2009. HCC was diagnosed principally on multiphasic computed tomography and magnetic resonance imaging scans of the liver. The tumor was staged according to the Barcelona Clinic Liver Cancer (BCLC) classification.
RESULTS: Altogether, 348 patients were diagnosed with HCC. There were 239 (68.7%) Chinese patients, 71 (20.4%) Malays and 38 (10.9%) Indians, with the median age of 62.5 years and the male to female ratio of 3.4:1. The predominant etiology in Malay and Chinese patients was hepatitis B virus infection (>60%) and in Indian patients was alcohol intake (26.3%) and cryptogenic cause (29.0%). Hepatitis C was seen in 18.3% of Malays, but less than 10% in Chinese and Indians. BCLC staging was: Stage A, 120 (34.5%); Stage B, 75 (21.6%); Stage C, 84 (24.1%); and Stage D, 69 (19.8%). A larger proportion of Indian than Chinese and Malays patients (44.7%) presented with stage D disease. Portal vein invasion was noted in 124 patients (35.6%) and extrahepatic metastases in 68 (19.5%). Surgical resection and radiofrequency ablation with curative intent was carried out in >90% of stage A patients and transarterial chemoembolization in 49.3% and 21.4% of stages B and C patients, respectively.
CONCLUSIONS: HCC is most common among Chinese, followed by Malays and Indians in Malaysia. The etiology of HCC shows a peculiar racial pattern.
© 2014 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  BCLC staging; Chinese; Indian; Malay; hepatocelluar carcinoma; multiracial Asian population

Mesh:

Substances:

Year:  2015        PMID: 25512092     DOI: 10.1111/1751-2980.12223

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  11 in total

Review 1.  Nonalcoholic fatty liver disease in Asia: emerging perspectives.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  J Gastroenterol       Date:  2016-09-16       Impact factor: 7.527

2.  Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.

Authors:  Huiyuan Qiu; Xiubing Zhang; Wenkai Ni; Weidong Shi; Hui Fan; Jian Xu; Yongmei Chen; Runzhou Ni; Tao Tao
Journal:  Dig Dis Sci       Date:  2015-11-09       Impact factor: 3.199

Review 3.  Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.

Authors:  Daniel Q Huang; Hashem B El-Serag; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-12-21       Impact factor: 46.802

Review 4.  The 2017 M Balasegaram Memorial Lecture: The Changing Landscape of Liver Diseases in Malaysia-60 Years On!

Authors:  Khean-Lee Goh
Journal:  Malays J Med Sci       Date:  2019-04-30

5.  Risk factors of hepatocellular carcinoma in type 2 diabetes patients: A two-centre study in a developing country.

Authors:  Noor Atika Azit; Shahnorbanun Sahran; Leow Voon Meng; Manisekar Subramaniam; Suryati Mokhtar; Azmawati Mohammed Nawi
Journal:  PLoS One       Date:  2021-12-09       Impact factor: 3.240

Review 6.  Hepatoprotective Potential of Malaysian Medicinal Plants: A Review on Phytochemicals, Oxidative Stress, and Antioxidant Mechanisms.

Authors:  Balu Alagar Venmathi Maran; Mohammad Iqbal; Prakash Gangadaran; Byeong-Cheol Ahn; Pasupuleti Visweswara Rao; Muhammad Dawood Shah
Journal:  Molecules       Date:  2022-02-24       Impact factor: 4.411

7.  Graphene Oxide Loaded with Protocatechuic Acid and Chlorogenic Acid Dual Drug Nanodelivery System for Human Hepatocellular Carcinoma Therapeutic Application.

Authors:  Kalaivani Buskaran; Mohd Zobir Hussein; Mohamad Aris Mohd Moklas; Mas Jaffri Masarudin; Sharida Fakurazi
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Incidence and mortality rates of colorectal cancer in Malaysia.

Authors:  Muhammad Radzi Abu Hassan; Ibtisam Ismail; Mohd Azri Mohd Suan; Faizah Ahmad; Wan Khamizar Wan Khazim; Zabedah Othman; Rosaida Mat Said; Wei Leong Tan; Siti Rahmah Noor Syahireen Mohammed; Shahrul Aiman Soelar; Nik Raihan Nik Mustapha
Journal:  Epidemiol Health       Date:  2016-03-09

Review 9.  Hepatocellular Carcinoma in Malaysia and Its Changing Trend.

Authors:  Ruksana Raihan; Amirah Azzeri; Fatiha H Shabaruddin; Rosmawati Mohamed
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01

10.  Analysis of inpatients' characteristics and spatio-temporal distribution of liver cancer incidence in Wuwei, Gansu Province, from 1995 to 2016: A long-term span retrospective study.

Authors:  Yang Zhang; Zhao Li; Zhongjun Shao; Kun Liu; Zhaohua Ji
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.